2021
DOI: 10.1016/j.jaad.2020.04.139
|View full text |Cite
|
Sign up to set email alerts
|

The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
82
1
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 95 publications
(84 citation statements)
references
References 18 publications
0
82
1
1
Order By: Relevance
“…Moreover, existing studies Fig. 1 Prevalence of lifetime and current parent-reported doctor-diagnosed psoriasis in the total study sample and by sex [21,28]. In the current study, the lifetime prevalence of parent-reported doctor-diagnosed psoriasis was estimated to be 3.6%, which is higher than the most extreme estimate reported in the literature among children, i.e., 2.1% in Italy [14].…”
Section: Discussioncontrasting
confidence: 40%
“…Moreover, existing studies Fig. 1 Prevalence of lifetime and current parent-reported doctor-diagnosed psoriasis in the total study sample and by sex [21,28]. In the current study, the lifetime prevalence of parent-reported doctor-diagnosed psoriasis was estimated to be 3.6%, which is higher than the most extreme estimate reported in the literature among children, i.e., 2.1% in Italy [14].…”
Section: Discussioncontrasting
confidence: 40%
“…22,23 In contrast, a recent study examining psoriasis on a global scale showed a higher burden of psoriasis in high-income countries, with Western Europe ranking second in a regional comparison of psoriasis prevalence. 24 It has been reported that higher socioeconomic status is associated with a higher prevalence and DALYs of atopic diseases. 25 A link between atopic diseases and particulate air pollution from motor vehicles has been previously shown.…”
Section: Discussionmentioning
confidence: 99%
“…23 Meanwhile, the incidence of this disease has been rising rapidly in China, the largest developing country in the world, over the past few decades. 3,4,24 However, relevant knowledge about the dysbiosis of gut microbiota (e.g., bacteria and fungi) in Chinese IBD patients is limited. [25][26][27] Therefore, in this study, we performed a molecular analysis of the bacterial and fungal microbiome of Chinese patients with CD and healthy Chinese subjects to explore the relative composition of the intestinal microbiota (bacteria and fungi) in the gut and their inter-and intra-kingdom interactions with intestinal inflammation.…”
Section: Characterization Of Fungal and Bacterial Dysbiosis In Young mentioning
confidence: 99%